Sparrow Pharmaceuticals
Portland, OR
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical developme... Read more
sparrowpharma.comCompany Details
Founded
- 2013
Employees
- Between 5 - 20 employees
Raised
- $156,275,264
Headquarters Location
- Portland, OR
Public
- No
Acquired
- No
CEO
Robert Jacks
Founders
- David Katz
Company Collections
These are collections Sparrow Pharmaceuticals is a part of. Click on the collection name to view similar companies.
Sparrow Pharmaceuticals' Industries
Sparrow Pharmaceuticals Headquarters Location
920 SW 6th Ave suite 1200, Portland, OR 97204
Total Amount Raised: $156,275,264
Sparrow Pharmaceuticals Funding Rounds
Series B
$95,000,000
Series B Investors
Forbion Capital PartnersRA Capital ManagementRiverVest Venture ManagementOrbiMed AdvisorsU.S. Venture Partners (USVP)Series Unknown
$10,200,000
Series Unknown Investors
OrbiMed AdvisorsU.S. Venture Partners (USVP)RiverVest Venture ManagementSeries A
$50,000,000
Series A Investors
OrbiMed AdvisorsU.S. Venture Partners (USVP)RiverVest Venture ManagementSeries Unknown
$1,075,255
Funding info provided by Diffbot.
Sparrow Pharmaceuticals Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Sparrow Pharmaceuticals.